Sorafenib in combination with transarterial chemoembolization in Chinese patients with hepatocellular carcinoma: a subgroup interim analysis of the START trial

Author: Han Guohong   Yang Jijin   Shao Guoliang   Teng Gaojun   Wang Maoqiang   Yang Jianyong   Liu Zhaoyu   Feng Gansheng   Yang Renjie   Lu Ligong   Chao Yee   Wang Jianhua  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.9, Iss.3, 2013-03, pp. : 403-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content